Table 1.
Characteristic | All patients |
---|---|
N = 40 | |
Age, mean (SD), years | 56 (13) |
Male gender, n (%) | 20 (50) |
Hispanic/white, n (%) | 40 (100) |
Language, n (%) | |
Spanish | 28 (70) |
English | 12 (30) |
Did not complete high school, n (%) | 25 (63) |
Married/domestic partner, n (%) | 16 (40) |
Employed, n (%) | 2 (5) |
Income, n (%) | |
Less than $15K | 33 (83) |
$15–30K | 7 (17) |
History of diabetes, n (%) | 30 (75) |
History of CVD, n (%) | 7 (18) |
Charlson comorbidity index score, mean standard deviation | 7.2 ± 2.7 |
Laboratory values, mean (SD) | |
Creatinine, mg/dL | 8.9 (3.7) |
Serum albumin, g/dL | 3.7 (0.5) |
Hemoglobin, g/dL | 10.4 (1.9) |
Phosphorus, mg/dL | 4.8 (1.4) |
KDQOL-36 SF, mean (SD) | |
Burden of kidney disease | 33 (27) |
Symptoms/problems | 68 (21) |
SF-12 physical health composite | 33 (1) |
SF-23 mental health composite | 45 (13) |
PHQ-9, median (IQR) | 4 (1,10) |
PHQ-9 ≥ 10, n (%) | 13 (30) |
ESAS-r:Renal, mean (SD) | |
Symptoms present | 6 (3) |
Symptoms moderate/severe | 5 (4) |
GAD-7, median (IQR) | 4 (1, 9) |
GAD-7 ≥ 10, n (%) | 10 (25) |
SD, standard deviation; KDQOL-SF, Kidney Dialysis Quality of Life Short Form; ESAS-r:Renal Modified Edmonton Symptom Assessment Scale; PHQ-9, Patient Health Questionnaire-9; GAD-7, Generalized Anxiety Disorder-7; IQR, interquartile range; CVD, cardiovascular disease.